MedTrace Logo

Red Maple Trials Cat Allergen Natural Exposure Chamber Validation in Cat-allergic Subjects

NCT03414801 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2018-08-24

No results posted yet for this study

Summary

To assess the reproducibility of the allergic response in the cat allergic subjects, measured as the change from baseline of the Total Nasal Symptom Score (TNSS) on the two challenge days.

Conditions

  • Allergic Rhinitis
  • Rhinoconjunctivitis
  • Exposure

Interventions

OTHER

Allergen Exposure

Subjects will undergo two exposure sessions, one week apart, of up to 1 hour depending on the subject's symptom severity and pulmonary function. During the exposure, subjects will be exposed to cat dander and levels of cat allergen, Fel d1, will be measured using sampling pumps with attached filters.

Sponsors & Collaborators

  • Ottawa Allergy Research Corporation

    collaborator UNKNOWN

  • Red Maple Trials Inc.

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-02-06
Primary Completion
2018-04-15
Completion
2018-07-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03414801 on ClinicalTrials.gov